• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct24
Huamao Pharmaceutical Announces Huansaijiu's Q1-Q3 2025 Performance
11:05
CR Sanjiu released FY2025 9 Months Earnings on October 24 After-Market (BJT), Actual Revenue CNY 21.99 B, Actual EPS CNY 1.4138
01:00
CR Sanjiu released FY2024 9 Months Earnings on October 24 After-Market (BJT), actual revenue CNY 19.74 B, actual EPS CNY 1.7798
01:00
CR Sanjiu released FY2024 Q3 earnings on October 24 After-Market (BJT), actual revenue CNY 5.634 B (forecast CNY 6.562 B), actual EPS CNY 0.3387 (forecast CNY 0.4588)
01:00
CR Sanjiu released FY2025 Q3 earnings on October 24 After-Market (BJT), actual revenue CNY 7.176 B (forecast CNY 7.279 B), actual EPS CNY 0.3277 (forecast CNY 0.3962)
01:00
Oct17
CR Sanjiu to Release FY2025 Q3 Earnings on October 25 After-Market (BJT), Forecast Revenue CNY 7.279 B, EPS CNY 0.4124
00:52

Schedules & Filings

Schedules
Filings
Oct24
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 7.176 B, Net Income 537.57 M, EPS 0.3277

Oct17
Distribution Plan(CST)

Cash dividend 0.45 CNY

Distribution Plan(CST)

Cash dividend 0.45 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More